Daclatasvir plus sofosbuvir for HCV infection: an oral combination therapy with high antiviral efficacy
- PMID: 24816173
- DOI: 10.1016/j.jhep.2014.04.042
Daclatasvir plus sofosbuvir for HCV infection: an oral combination therapy with high antiviral efficacy
Keywords: Daclatasvir; Direct-acting antivirals; Faldaprevir; Simeprevir; Sofosbuvir.
Comment on
-
Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection.N Engl J Med. 2014 Jan 16;370(3):211-21. doi: 10.1056/NEJMoa1306218. N Engl J Med. 2014. PMID: 24428467 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
